Spatial distribution and determinants of tetanus toxoid immunization among pregnant women in Ethiopia using data from Ethiopian demographic and health survey 2016

Springer Science and Business Media LLC - Tập 23 - Trang 1-9 - 2023
Beletech Fentie1, Tewodros Getaneh Alemu1, Masresha Asmare Techane1, Chalachew Adugna Wubneh1, Nega Tezera Assimamaw1, Getaneh Mulualem Belay1, Tadesse Tarik Tamir1, Addis Bilal Muhye1, Destaye Guadie Kassie1, Amare Wondim1, Bewuketu Terefe2, Bethelihem Tigabu Tarekegn1, Mohammed Seid Ali1, Almaz Tefera Gonete1, Berhan Tekeba1, Selam Fisiha Kassa1, Bogale Kassahun Desta1, Amare Demsie Ayele1, Melkamu Tilahun Dessie1, Kendalem Asmare Atalell1
1Department of Pediatrics and Child Health Nursing, School of Nursing, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia
2Department of Community Health Nursing, School of Nursing, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia

Tóm tắt

Tetanus is a major public health problem caused by clostridium tetani. Although it is vaccine-preventable, the case fatality rate among neonates in areas with poor immunization coverage and limited access to clean deliveries reaches 80-100%. Vaccination of pregnant mothers with the tetanus toxoid (TT) vaccine is the most effective way to protect against neonatal tetanus. This study aimed to examine the spatial distribution and determinants of tetanus toxoid immunization among pregnant mothers using the 2016 EDHS data. Secondary analysis of the Ethiopia Demographic and Health Survey 2016 was done to assess the spatial distribution and determinants of tetanus toxoid vaccine among pregnant women in Ethiopia. Spatial autocorrelation analysis and hot spot analysis were used to detect spatial dependency and spatial clustering of the tetanus toxoid vaccine in Ethiopia. Spatial interpolation was used to predict the tetanus toxoid vaccine coverage in unsampled areas. The multilevel binary logistic regression model was fitted to identify factors associated with tetanus toxoid vaccination. An adjusted odds ratio with 95% CI was calculated and used as the measure of association and a p-value less than 0.05 were considered statistically significant. From the total of 7043 pregnant women, 42.4% of them have taken at least two doses of tetanus toxoid immunization. Spatial clustering of TT immunization was observed in the Northern, Southwestern and Southwestern parts of Ethiopia. Whereas, low TT coverage was observed in the Eastern and Western parts of the country. Increased ANC visits and the richest economic status favored TT immunization, whereas living in Addis Ababa and Dire Dewa cities decreased the TT immunization coverage. The finding of this study reveals that TT immunization had spatial dependency, with the highest immunization coverage observed in the Northern, Southwestern and Southeastern parts of the Country. Thus, geographically targeted interventions should be implemented particularly in the eastern and western parts of the country.

Tài liệu tham khảo

Dietz V, et al. Performance and potency of tetanus toxoid: implications for eliminating neonatal tetanus. Bull World Health Organ. 1996;74(6):619. Singh A, et al. Maternal tetanus toxoid vaccination and neonatal mortality in rural north India. PLoS ONE. 2012;7(11):e48891. Vandelaer J, et al. Tetanus in developing countries: an update on the maternal and neonatal Tetanus Elimination Initiative. Vaccine. 2003;21(24):3442–5. Kalaça S, Yalçın M, Yavuz S. Missed opportunities for tetanus vaccination in pregnant women, and factors associated with seropositivity. Public Health. 2004;118(5):377–82. Yusuf N, et al. Progress and barriers towards maternal and neonatal tetanus elimination in the remaining 12 countries: a systematic review. The Lancet Global Health. 2021;9(11):e1610–7. Maral I, et al. Tetanus immunization in pregnant women: evaluation of maternal tetanus vaccination status and factors affecting rate of vaccination coverage. Public Health. 2001;115(5):359–64. Njuguna HN, et al. Progress toward maternal and neonatal tetanus elimination—worldwide, 2000–2018. Morb Mortal Wkly Rep. 2020;69(17):515. Duclos P, et al. Global immunization: status, progress, challenges and future. BMC Int health Hum rights. 2009;9(1):1–11. Yusuf N, et al. Progress and barriers towards maternal and neonatal tetanus elimination in the remaining 12 countries. The Lancet Global Health. 2021;9(11):e1610–7. Tikmani SS et al. Trends of antenatal care during pregnancy in low-and middle-income countries: findings from the global network maternal and newborn health registry. Seminars in perinatology. 2019. Elsevier. Yaya S, et al. Antenatal visits are positively associated with uptake of tetanus toxoid and intermittent preventive treatment in pregnancy in Ivory Coast. BMC Public Health. 2019;19(1):1–12. Haile ZT, Chertok IRA, Teweldeberhan AK. Determinants of utilization of sufficient tetanus toxoid immunization during pregnancy: evidence from the Kenya demographic and health survey, 2008–2009. J Community Health. 2013;38(3):492–9. Gebremedhin TS et al. Tetanus toxoid vaccination uptake and associated factors among mothers who gave birth in the last 12 months in Errer District, Somali Regional State, Eastern Ethiopia BioMed Research International, 2020. 2020. Dubale Mamoro M, Kelbiso L, Hanfore. Tetanus toxoid immunization status and associated factors among mothers in Damboya Woreda, Kembata Tembaro zone, SNNP, Ethiopia Journal of nutrition and metabolism, 2018. 2018. Anatea MD, Mekonnen TH, Dachew BA. Determinants and perceptions of the utilization of tetanus toxoid immunization among reproductive-age women in Dukem Town, Eastern Ethiopia: a community-based cross-sectional study. BMC Int health Hum rights. 2018;18(1):1–10. Yaya S, et al. Prevalence and predictors of taking tetanus toxoid vaccine in pregnancy: a cross-sectional study of 8,722 women in Sierra Leone. BMC Public Health. 2020;20(1):855. Gessesse DN, et al. Coverage and determinants of protective dose tetanus toxoid vaccine among postnatal women delivered at university of Gondar comprehensive specialized hospital, northwest Ethiopia, 2019. Clin Epidemiol Global Health. 2021;12:100814. Mohamed SOO, Ahmed EM. Prevalence and determinants of antenatal tetanus vaccination in Sudan: a cross-sectional analysis of the multiple Indicator Cluster Survey. Trop Med Health. 2022;50(1):1–6. Yaya S, et al. Prevalence and predictors of taking tetanus toxoid vaccine in pregnancy: a cross-sectional study of 8,722 women in Sierra Leone. BMC Public Health. 2020;20:1–9. Mehari K, Wencheko E. Factors affecting maternal health care services utilization in rural Ethiopia: a study based on the 2011 EDHS data. Ethiop J Health Dev. 2013;27(1):16–24. Ahmed A, El-Berrawy M. Factors affecting maternal tetanus vaccination in Dakahlia Governorate, Egypt. J High Inst Public Health. 2019;49(1):30–5. Anatea MD, Mekonnen TH, Dachew BA. Determinants and perceptions of the utilization of tetanus toxoid immunization among reproductive-age women in Dukem Town, Eastern Ethiopia: a community-based cross-sectional study. BMC Int Health Hum Rights. 2018;18(1):27. Mihret MS, Limenih MA, Gudayu TW. The role of timely initiation of antenatal care on protective dose tetanus toxoid immunization: the case of northern Ethiopia post natal mothers. BMC Pregnancy Childbirth. 2018;18(1):235. Edet EE, et al. Factors associated with missed opportunities to immunise with tetanus toxoid at a tertiary health institution in Nigeria. Cent Afr J Med. 1998;44(8):199–202. Belay AT, et al. Prevalence and risk factors associated with rural women’s protected against tetanus in East Africa: evidence from demographic and health surveys of ten east african countries. PLoS ONE. 2022;17(3):e0265906. Yeshaw Y, et al. Factors associated with births protected against neonatal tetanus in Africa: Evidences from demographic and health surveys of five african countries. PLoS ONE. 2021;16(6):e0253126.